載入...
Novel M(2)‐selective, G(i)‐biased agonists of muscarinic acetylcholine receptors
BACKGROUND AND PURPOSE: More than 30% of currently marketed medications act via GPCRs. Thus, GPCRs represent one of the most important pharmacotherapeutic targets. In contrast to traditional agonists activating multiple signalling pathways, agonists activating a single signalling pathway represent a...
Na minha lista:
| 發表在: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161557/ https://ncbi.nlm.nih.gov/pubmed/31910288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14970 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|